Tag: FDA

September 8, 2025

FDA Digital Leader Joins Mayo Clinic Team

September 8, 2025

FDA Breakthrough Therapy Designation for Olomorasib + Pembrolizumab in NSCLC

September 4, 2025

7 Pulmonology Headlines – August 2025

September 4, 2025

Bimekizumab: Psoriasis Treatment Outperforms Active Comparators

August 29, 2025

ACC Respiratory Disease Vaccination Guidelines for Adults with Heart Disease

August 28, 2025

Gedatolisib FDA Review: HR+/HER2- Breast Cancer & PIK3CA

August 28, 2025

FDA Ends Emergency Use Authorization for COVID Vaccines

August 27, 2025

World Allergy Organization Updates NSAID Hypersensitivity Classification

August 25, 2025

Rusfertide Breakthrough Therapy Designation for Polycythemia Vera

August 23, 2025

HHS Union Rights: Workers Face Potential Loss of Representation

August 22, 2025

FDA Daily Drug Adverse Event Reports

August 21, 2025

Esketamine Dexmedetomidine Sleep Insomnia Depression

August 21, 2025

New Cancer Drugs: Uncertainties & FDA Labeling Issues

August 21, 2025

Dyslipidemia Parkinson’s Risk: Metabolic Syndrome Connection

August 20, 2025

Food Allergy Treatment: Efficacy Over Method & Frequency

August 19, 2025

Systemic Inflammation & Healthcare Costs: ASCVD, CKD